NIH-funded research NIH-funded research

Glucocorticoids and critical illness outcomes in ICU patients

Official title: Glucocorticoids in short- and long-term critical illness outcomes

Funded at Columbia University Health Sciences · NIH-11580346 · Data updated 2026-11-12

A researcher team at Columbia University will study how glucocorticoids affect short- and long-term outcomes for people who survive critical illness, including mental health and recovery aspects.

More Critical Illness research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 1, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$376,462
NIH project number7R35GM154671-04
Project IDNIH-11580346 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have survived critical illness, including sepsis survivors, who meet study criteria.

Less likely to help

People not fitting the study’s specific sepsis survivor or brainstem/glucocorticoid pathway criteria may not benefit.

What this research studies

This project explores how glucocorticoids influence recovery after severe illness, with a focus on mechanisms in the brain and body. Researchers plan to study sepsis survivors to see if glucocorticoids improve mental health outcomes by shaping ICU memories, and to examine brainstem glucocorticoid signaling in maintaining cardiovascular and immune balance during acute stress. The work includes testing receptor roles in the brainstem and trying new approaches to boost glucocorticoid sensitivity peripherally and centrally, using methods for neural circuit interrogation. The study aims to connect biological pathways to meaningful improvements in survival and quality of life after critical illness.

Why it matters

Potential benefit: If successful, patients recovering from critical illness could see improved survival and better mental and physical health during recovery.

How similar studies have gone: Prior work suggests glucocorticoids can affect short-term survival and mental health, but many mechanisms remain uncertain and this program seeks to clarify them.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Spencer-Segal, Joanna Louise — Columbia University Health Sciences
  • Study coordinator: Spencer-Segal, Joanna Louise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.